Arthritis & Rheumatism · 1992 · 74 citations · 12 references
Life SciencesImmunologyInternal MedicineAutoimmunityImmunopathologyRheumatologyAutoantibodiesAutoantigensAutoimmune DiseasesGenetic Susceptibility To AutoimmunitySystemic Autoimmune DiseaseSystemic SclerosisAnti-topoisomerase I AntibodiesAntibodiesAntinuclear Antibody PositivityAutoantibodies In Rheumatic DiseaseAutoimmune SerologyTissue AutoantibodiesTopoisomerase ActivityTopoisomerase I Autoantigen
OBJECTIVE: To determine demographic differences in scleroderma-related autoantibodies. METHODS: One hundred fifty-six patients with systemic sclerosis were prospectively examined for anticentromere antibodies (ACA), anti-topoisomerase I (anti-topo I, or Scl-70), antinucleolar, and anti-U1 RNP autoantibodies. RESULTS: ACA was found in 36% of Caucasians and 4% of American blacks (P = 0.002, odds ratio [OR] 15). Anti-topo I was found in 37% of American blacks, compared with 17% of Caucasians (P = 0.04, OR 3). No significant differences in the frequencies of antinucleolar and anti-U1 RNP autoantibodies were found. CONCLUSION: These data suggest important demographic differences in scleroderma-associated autoantibodies.
12
Diversity of antinuclear antibodies in progressive systemic sclerosis
Eng M. Tan, Gerald P. Rodnan, Ignacio García‐De La Torre et al. · Arthritis & Rheumatism · 1980 · 526 citations
Life Sciences, Immunology, Pathology +11
High Titers of Autoantibodies to Topoisomerase I (Scl-70) in Sera from Scleroderma Patients
J. H. Shero, Bonnie J. Bordwell, N Rothfield et al. · Science · 1986 · 308 citations